Eterna Therapeutics Q4 EPS $(1.24) May Not Compare To $(2.40) Estimate
Eterna Therapeutics (NASDAQ:ERNA) reported quarterly losses of $(1.24) per share which beat the analyst consensus estimate of $(2.40) by 48.33 percent. This is a 61.25 percent increase over losses of $(3.20) per share
